These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17092972)

  • 21. Imaging of the brain serotonin transporters (SERT) with 18F-labelled fluoromethyl-McN5652 and PET in humans.
    Hesse S; Brust P; Mäding P; Becker GA; Patt M; Seese A; Sorger D; Zessin J; Meyer PM; Lobsien D; Laudi S; Habermann B; Füchtner F; Luthardt J; Bresch A; Steinbach J; Sabri O
    Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):1001-11. PubMed ID: 22349718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of molecular imaging of serotonin transporters in ecstasy/polydrug users.
    Roberts CA; Jones A; Montgomery C
    Neurosci Biobehav Rev; 2016 Apr; 63():158-67. PubMed ID: 26855234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain serotonin transporter binding in former users of MDMA ('ecstasy').
    Selvaraj S; Hoshi R; Bhagwagar Z; Murthy NV; Hinz R; Cowen P; Curran HV; Grasby P
    Br J Psychiatry; 2009 Apr; 194(4):355-9. PubMed ID: 19336788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [(11)C]McN 5652.
    Simpson HB; Lombardo I; Slifstein M; Huang HY; Hwang DR; Abi-Dargham A; Liebowitz MR; Laruelle M
    Biol Psychiatry; 2003 Dec; 54(12):1414-21. PubMed ID: 14675806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limitations of bi-linear regression analysis for the determination of receptor occupancy with positron emission tomography.
    Buchert R; Varga J; Mester J
    Nucl Med Commun; 2004 May; 25(5):451-9. PubMed ID: 15100503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography.
    Jarkas N; McConathy J; Votaw JR; Voll RJ; Malveaux E; Camp VM; Williams L; Goodman RR; Kilts CD; Goodman MM
    Nucl Med Biol; 2005 Jan; 32(1):75-86. PubMed ID: 15691664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PET brain imaging with [11C](+)McN5652 shows increased serotonin transporter availability in major depression.
    Reivich M; Amsterdam JD; Brunswick DJ; Shiue CY
    J Affect Disord; 2004 Oct; 82(2):321-7. PubMed ID: 15488265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic analysis of [11C]McN5652: a serotonin transporter radioligand.
    Szabo Z; Scheffel U; Mathews WB; Ravert HT; Szabo K; Kraut M; Palmon S; Ricaurte GA; Dannals RF
    J Cereb Blood Flow Metab; 1999 Sep; 19(9):967-81. PubMed ID: 10478648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance.
    McCann UD; Szabo Z; Vranesic M; Palermo M; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
    Psychopharmacology (Berl); 2008 Oct; 200(3):439-50. PubMed ID: 18661256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methods.
    Frankle WG; Slifstein M; Gunn RN; Huang Y; Hwang DR; Darr EA; Narendran R; Abi-Dargham A; Laruelle M
    J Nucl Med; 2006 May; 47(5):815-26. PubMed ID: 16644752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positron emission tomography imaging of serotonin transporters in the human brain using [11C](+)McN5652.
    Szabo Z; Kao PF; Scheffel U; Suehiro M; Mathews WB; Ravert HT; Musachio JL; Marenco S; Kim SE; Ricaurte GA
    Synapse; 1995 May; 20(1):37-43. PubMed ID: 7624828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.
    Urban NB; Girgis RR; Talbot PS; Kegeles LS; Xu X; Frankle WG; Hart CL; Slifstein M; Abi-Dargham A; Laruelle M
    Neuropsychopharmacology; 2012 May; 37(6):1465-73. PubMed ID: 22353758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simple and rapid quantification of serotonin transporter binding using [
    Gryglewski G; Rischka L; Philippe C; Hahn A; James GM; Klebermass E; Hienert M; Silberbauer L; Vanicek T; Kautzky A; Berroterán-Infante N; Nics L; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
    Neuroimage; 2017 Apr; 149():23-32. PubMed ID: 28119137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation of two serotonin transporter ligands in the human brain: [(11)C](+)McN5652 and [(11)C]cyanoimipramine.
    Takano A; Suhara T; Sudo Y; Inoue M; Hashimoto K; Zhang MR; Ichimiya T; Yasuno F; Suzuki K
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1289-97. PubMed ID: 12271409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the Serotonin Transporter Ligand 123I-ADAM for SPECT Studies on Humans.
    Frokjaer VG; Pinborg LH; Madsen J; de Nijs R; Svarer C; Wagner A; Knudsen GM
    J Nucl Med; 2008 Feb; 49(2):247-54. PubMed ID: 18199621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tracer kinetic modeling of [(11)C]AFM, a new PET imaging agent for the serotonin transporter.
    Naganawa M; Nabulsi N; Planeta B; Gallezot JD; Lin SF; Najafzadeh S; Williams W; Ropchan J; Labaree D; Neumeister A; Huang Y; Carson RE
    J Cereb Blood Flow Metab; 2013 Dec; 33(12):1886-96. PubMed ID: 23921898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys.
    Banks ML; Czoty PW; Gage HD; Bounds MC; Garg PK; Garg S; Nader MA
    Neuropsychopharmacology; 2008 Jan; 33(2):219-25. PubMed ID: 17443127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin transporter availability in thalamic subregions in schizophrenia: a study using 7.0-T MRI with [(11)C]DASB high-resolution PET.
    Kim JH; Son YD; Kim JH; Choi EJ; Lee SY; Lee JE; Cho ZH; Kim YB
    Psychiatry Res; 2015 Jan; 231(1):50-7. PubMed ID: 25465315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positron emission tomography imaging of the serotonin transporter in subjects with a history of alcoholism.
    Szabo Z; Owonikoko T; Peyrot M; Varga J; Mathews WB; Ravert HT; Dannals RF; Wand G
    Biol Psychiatry; 2004 Apr; 55(7):766-71. PubMed ID: 15039007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.
    Reneman L; de Win MM; van den Brink W; Booij J; den Heeten GJ
    J Psychopharmacol; 2006 Mar; 20(2):164-75. PubMed ID: 16510475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.